A Biotech ETF Gets Its Groove Back
February 17, 2017 at 10:55 AM EST
After struggling through one of its worst annual performances in several years in 2016, the SPDR S&P Biotech ETF (NYSEArca: XBI), the third-largest biotechnology exchange traded fund, is surging to start 2017. XBI, which is an equal-weight ETF with significant exposure to smaller biotechnology...
